These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 25142637)

  • 21. Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia's National Childhood vaccine schedule.
    Buttery JP; Lambert SB; Grimwood K; Nissen MD; Field EJ; Macartney KK; Akikusa JD; Kelly JJ; Kirkwood CD
    Pediatr Infect Dis J; 2011 Jan; 30(1 Suppl):S25-9. PubMed ID: 21183837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of NITAG policies and working processes in selected developed countries.
    Ricciardi GW; Toumi M; Weil-Olivier C; Ruitenberg EJ; Dankó D; Duru G; Picazo J; Zöllner Y; Poland G; Drummond M
    Vaccine; 2015 Jan; 33(1):3-11. PubMed ID: 25258100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rotavirus vaccines: targeting the developing world.
    Glass RI; Bresee JS; Turcios R; Fischer TK; Parashar UD; Steele AD
    J Infect Dis; 2005 Sep; 192 Suppl 1():S160-6. PubMed ID: 16088799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decision support in vaccination policies.
    Piso B; Wild C
    Vaccine; 2009 Oct; 27(43):5923-8. PubMed ID: 19698809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The cost-effectiveness of pentavalent rotavirus vaccination in England and Wales.
    Atkins KE; Shim E; Carroll S; Quilici S; Galvani AP
    Vaccine; 2012 Nov; 30(48):6766-76. PubMed ID: 23000223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rotavirus vaccines in developing countries: the potential impact, implementation challenges, and remaining questions.
    Cherian T; Wang S; Mantel C
    Vaccine; 2012 Apr; 30 Suppl 1():A3-6. PubMed ID: 22520133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rotavirus vaccination.
    Bjur KA; Jacobson RM
    Minerva Pediatr; 2009 Oct; 61(5):515-21. PubMed ID: 19794377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Supporting evidence-based rotavirus vaccine introduction decision-making and implementation: Lessons from 8 Gavi-eligible countries.
    Jennings MC; Sauer M; Manchester C; Soeters HM; Shimp L; Hyde TB; Parashar U; Burgess C; Castro B; Hossein I; Othepa M; Payne DC; Tate JE; Walldorf J; Privor-Dumm L; Richart V; Santosham M;
    Vaccine; 2024 Jan; 42(1):8-16. PubMed ID: 38042696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rotavirus vaccination in Europe: drivers and barriers.
    Parez N; Giaquinto C; Du Roure C; Martinon-Torres F; Spoulou V; Van Damme P; Vesikari T
    Lancet Infect Dis; 2014 May; 14(5):416-25. PubMed ID: 24758998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Time to begin a new chapter and expand rotavirus immunization.
    Anderson EJ
    Clin Infect Dis; 2014 Oct; 59(7):982-6. PubMed ID: 24944227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness of a pentavalent human-bovine reassortant rotavirus vaccine for children ≤5 years of age in Taiwan.
    Itzler RF; Chen PY; Lac C; El Khoury AC; Cook JR
    J Med Econ; 2011; 14(6):748-58. PubMed ID: 21919673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A review of rotavirus infection in and vaccination of human immunodeficiency virus-infected children.
    Steele AD; Cunliffe N; Tumbo J; Madhi SA; De Vos B; Bouckenooghe A
    J Infect Dis; 2009 Nov; 200 Suppl 1():S57-62. PubMed ID: 19817615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Health economics of rotavirus immunization in Vietnam: potentials for favorable cost-effectiveness in developing countries.
    Tu HA; Rozenbaum MH; Coyte PC; Li SC; Woerdenbag HJ; Postma MJ
    Vaccine; 2012 Feb; 30(8):1521-8. PubMed ID: 22119590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Economic evaluations of rotavirus immunization for developing countries: a review of the literature.
    Tu HA; Woerdenbag HJ; Kane S; Rozenbaum MH; Li SC; Postma MJ
    Expert Rev Vaccines; 2011 Jul; 10(7):1037-51. PubMed ID: 21806398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rotavirus vaccination in central Europe.
    Mészner Z; Anca I; André F; Chlibek R; Čižman M; Grzesiowski P; Mangarov A; Pokorn M; Prymula R; Richter D; Salman N; Šimurka P; Tamm E; Tešović G; Urbancikova I; Usonis V; Zavadska D;
    J Pediatr Gastroenterol Nutr; 2013 Jun; 56(6):586-96. PubMed ID: 23708638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Global rotavirus surveillance: determining the need and measuring the impact of rotavirus vaccines.
    Widdowson MA; Steele D; Vojdani J; Wecker J; Parashar U
    J Infect Dis; 2009 Nov; 200 Suppl 1():S1-8. PubMed ID: 19817589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Recommendations for the use of rotavirus vaccines in industrialized countries].
    Franco E
    Ig Sanita Pubbl; 2006; 62(6):697-700. PubMed ID: 17256023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estimating the costs of implementing the rotavirus vaccine in the national immunisation programme: the case of Malawi.
    Madsen LB; Ustrup M; Hansen KS; Nyasulu PS; Bygbjerg IC; Konradsen F
    Trop Med Int Health; 2014 Feb; 19(2):177-85. PubMed ID: 24314006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rotavirus vaccination within the South African Expanded Programme on Immunisation.
    Seheri LM; Page NA; Mawela MP; Mphahlele MJ; Steele AD
    Vaccine; 2012 Sep; 30 Suppl 3():C14-20. PubMed ID: 22939015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Vaccination against chickenpox, shingles and rotavirus-infection].
    Hartwig NG; Rümke HC; Visser HK
    Ned Tijdschr Geneeskd; 2009; 153():A913. PubMed ID: 19900343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.